A detailed history of Prudential Financial Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 376,645 shares of RLAY stock, worth $2.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
376,645
Previous 450,345 16.37%
Holding current value
$2.11 Million
Previous $2.94 Million 9.2%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$6.23 - $9.51 $459,151 - $700,887
-73,700 Reduced 16.37%
376,645 $2.67 Million
Q2 2024

Aug 13, 2024

BUY
$5.9 - $8.02 $518,580 - $704,917
87,895 Added 24.25%
450,345 $2.94 Million
Q1 2024

May 14, 2024

BUY
$7.5 - $12.07 $2.72 Million - $4.37 Million
362,450 New
362,450 $3.01 Million
Q3 2020

Nov 16, 2020

BUY
$32.81 - $45.1 $170,940 - $234,971
5,210 New
5,210 $222,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $673M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.